Marijuana Business Factbook 2019

Marijuana Business Factbook 2019 Chapter 2 | State-By-State: Legal Overview, Market Data and Outlook 64 © Copyright 2020, Marijuana Business Daily , a division of Anne Holland Ventures Inc. You may NOT copy this Factbook, or make public the data and facts contained herein, in part or in whole. For more copies or editorial permissions, contact CustomerService@MJBizDaily.com or call (720) 213-5992, ext. 1. GEORGIA Medical REGULATORY OVERVIEW Main measure HB 1: Develops a patient registry and allows patients to posses and use low-THC oil HB 324: Provides for the production, manufacturing and dispensing of low-THC oil Type of measure Legislative bills Year passed HB 1: 2015 HB 324: 2019 Margin of victory HB 1: 160 to 9 in the House, 48 to 6 in the Senate HB 324: 147 to 16 in the House, 34 to 20 in the Senate Possession limit 20 fluid ounces of low-THC oil Patient registry Mandatory―patients must have certification from a physician Accepts patients registered with other states? No Home cultivation No Restrictions on type of marijuana allowed to be sold? Yes―flower, edibles and vaping are prohibited. The program only allows for oil with THC content of 5% or less in the forms of oil, tinctures, transdermal patches, lotion or capsules. Vaping or smoking oil is strictly prohibited. Qualifying medical conditions AIDS (severe or end stage), ALS (severe or end stage), Alzheimer’s, autism spectrum disorder, cancer (end stage or when treatment causes cachexia or vomiting), Crohn’s disease, seizure disorders related to epilepsy or head trauma, multiple sclerosis (severe or end stage), mitochondrial disease, Parkinson’s disease (severe or end stage), sickle cell disease (severe or end stage), Tourette syndrome (severe), epidermolysis bullosa, peripheral neuropathy (severe or end stage), hospice care, intractable pain, PTSD